| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/05/2005 | CN1559384A Injection temp-sensing type implanting prepns. |
| 01/05/2005 | CN1183127C Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 01/05/2005 | CN1183112C PEG-inerferon conjugate |
| 01/05/2005 | CN1182904C Methods for extraction and reaction using supercritical fluids |
| 01/05/2005 | CN1182873C Arginine silicate inositol complex and use thereof |
| 01/05/2005 | CN1182872C Use of (meth) acrylic acid copolymers to increase permeability of mucous membranes |
| 01/05/2005 | CN1182870C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 01/05/2005 | CN1182844C Use of dialkylfumarates |
| 01/05/2005 | CN1182841C New pharmaceutical formulation and preparation process |
| 01/05/2005 | CN1182840C Coated medicament forms with controlled active substance release |
| 01/05/2005 | CN1182838C Intraorally soluble compressed preparation and process for producing the same |
| 01/05/2005 | CN1182837C Orally administrable immediate and prolonged-release Galenic form comprising absorption-promoting agent and use of this absorption-promoting agent |
| 01/05/2005 | CN1182834C Usage of water soluble beta (1,3) glucosan of nano scalar |
| 01/04/2005 | US6838528 Absorption, bioavailability |
| 01/04/2005 | US6838450 Residue of a drug compound such as antineoplastic agents and a carboxy(C1-4) alkyldextran polyalcohol obtained by treating a dextran under conditions that enable substantially complete polyalcoholization are bound to each other by means of a |
| 01/04/2005 | US6838449 Ophthalmic compositions containing galactomannan polymers and borate |
| 01/04/2005 | US6838429 Atopic dermatitis treatment method |
| 01/04/2005 | US6838260 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/04/2005 | US6838236 Comprises human immunodeficiency virus viral protein r (VPR) for treating and preventing cancer and viral diseases |
| 01/04/2005 | US6838095 Substantially non-colloidal solution made by combining ingredients comprising (a) water; (b) a source of free silver ions; and (c) a substantially non-toxic, substantially thiol-free, substantially water-soluble complexing agent. |
| 01/04/2005 | US6838093 System for osmotic delivery of pharmaceutically active agents |
| 01/04/2005 | US6838091 Lipid-regulating agent, particularly fenofibrate, dissolved in a monoglyceride. |
| 01/04/2005 | US6838090 Water-insoluble drug delivery system |
| 01/04/2005 | US6838089 Vaccines; immunogens; for Helicobacter infections |
| 01/04/2005 | US6838084 For connection with major histomcompatability complex molecules |
| 01/04/2005 | US6838078 Film-forming compositions and methods |
| 01/04/2005 | US6838076 Pulmonary administration of chemically modified insulin |
| 01/04/2005 | US6838075 For aerosolized delivery to lungs |
| 01/04/2005 | US6838073 Cobalamin conjugates useful as imaging and therapeutic agents |
| 01/04/2005 | US6837696 Apparatus for manufacturing dosage forms |
| 01/04/2005 | CA2470262A1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 01/04/2005 | CA2434685A1 Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a |
| 01/04/2005 | CA2434668A1 Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a |
| 01/04/2005 | CA2301503C Pharmaceutical compositions for oral administration of molecular iodine |
| 01/04/2005 | CA2285023C High avidity polyvalent and polyspecific reagents |
| 01/04/2005 | CA2092349C Biopolymer composites |
| 12/30/2004 | US20040268425 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms |
| 12/30/2004 | US20040266994 Type-1 ribosome-inactivating protein |
| 12/30/2004 | US20040266965 polymerization of 2-hydroxyethyl methacrylate and ethylene glycol dimethacrylate in water, then drying to form powder; cosmetics |
| 12/30/2004 | US20040266877 Stable liquid oral dosage pharmaceutical composition, comprising at least one thyroid hormone, 40% to 96% of ethanol by volume, a pH adjusting agent so that measured pH of composition is 9 to 12, and 4% to 50% water by volume; accurately delivers small doses of thyroid hormone; long shelf life |
| 12/30/2004 | US20040266869 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 12/30/2004 | US20040266858 Comprising water and 0.001 to 30% by weight of alpha -lipoic acid or a derivative thereof based on total weight of solution and having ph of 0.0-6.5; use in pharmaceutical, cosmetic or dietary products, in particular within framework of a supplementary or combination therapy or as solution for infusion |
| 12/30/2004 | US20040266806 Autoclaved methylnaltrexone preparation having reduced level of degradation products; storage stability; kits |
| 12/30/2004 | US20040266747 Long chain fatty alcohol substituents in antineoplastic agents |
| 12/30/2004 | US20040266725 Polysaccharide-containing compositions and use thereof |
| 12/30/2004 | US20040266710 Immunotherapy; induce immunology response |
| 12/30/2004 | US20040266709 Immunotherapy; induction immunology response |
| 12/30/2004 | US20040266702 Topical treatment or prevention of ocular infections |
| 12/30/2004 | US20040266696 activating neovascularization by administering heptapeptides having replacements in the amino acid sequence; antiischemic agents; regeneration and maintenance of artificial bones |
| 12/30/2004 | US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/30/2004 | US20040266678 Methods and compositions for treating polycystic ovary syndrome |
| 12/30/2004 | US20040266026 Hybrid immobilized catalytic system with controlled permeability |
| 12/30/2004 | US20040266004 Method of promoting nucleic acid transfer |
| 12/30/2004 | US20040265954 Transgenic escherichia for use in the expression and propagation of N-glycosylated target proteins; bioreactors and heterologous protein expression |
| 12/30/2004 | US20040265951 Biomimetic gelation system for use as surgical sealant and medical adhesive |
| 12/30/2004 | US20040265927 Phospho-amino acid end groups interact with receptors on antigen-presenting cells; for treatment of T-cell mediated disorders (autoimmune conditions), inflammatory disorders, neurodegenerative disorders, and endothelial dysfunction disorders |
| 12/30/2004 | US20040265879 peptide nucleic acid conjugate of a nucleic acid analog covalently linked to a peptide transporter moiety; enhance antisense activity; drug delivery; conjugate is a morpholino-base with phosphorodiamidate linkages with a peptide such as Arg9Phe2 (arginine9phenylalanine2) |
| 12/30/2004 | US20040265852 Diangnosis and treatment of AUR1 and/or AUR2 related disorders |
| 12/30/2004 | US20040265392 Nanoparticles comprising biologically active tnf which is immobilized on the same |
| 12/30/2004 | US20040265389 Degradable gel and method for producing the same |
| 12/30/2004 | US20040265388 Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses |
| 12/30/2004 | US20040265386 Gel compositions |
| 12/30/2004 | US20040265384 Composition for soluble films with a new hydrolyzed polysaccharide |
| 12/30/2004 | US20040265383 Compositions for parenteral administration and sustained-release of therapeutic agents |
| 12/30/2004 | US20040265376 Orally deliverable; enhanced bioavailability; encapsulated in dissolution resistant material |
| 12/30/2004 | US20040265371 Hemostatic devices and methods of making same |
| 12/30/2004 | US20040265362 Adhesive, skin and/or nail permeation enhancer; drug contained in contact layer; and binders, crosslinking agents, softeners, solvents, fillers and/or antioxidants; occlusive backing; fungal infection treatment of onychomycosis |
| 12/30/2004 | US20040265354 Formulations for coated microprojections containing non-volatile counterions |
| 12/30/2004 | US20040265353 Delivering benzodiazepine drug comprising alprazolam, lorazepam, clonazepam, or midazolam; forming a depot beneath skin surface; attenuates panic attack if delivered into systemic circulation; applying microwave, exothermic, or electric heat to skin surface |
| 12/30/2004 | US20040265350 Ceramic carrier comprising interconnected skeleton of scaffolding and struts having pores; low density; time-release agents; fibroblast-, or transforming growth factors; bone morphogenic proteins, somatotrophin; antibiotics, vitamins, proteins, hormones, radiopacity agents |
| 12/30/2004 | US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target |
| 12/30/2004 | US20040265299 Comprising dextrin, starch, peach resin and magnesium stearate; use in hyperthyroidism therapy; reduce serum thyroid hormones level by binding thyroid hormones which is excreted to intestinal tract; hormone inhibitors |
| 12/30/2004 | US20040265293 Heating to increase the loading efficiency of trehalose into the platelets; incubating at 37 degrees C.; preserves biological properties of loaded platelets during freeze-drying and rehydration |
| 12/30/2004 | US20040265270 recombinant; Interferons; stabilized with a polyol, a non-reducing sugar or a amino acid; acetate buffer, albumin; mannitol, saccharose and glycine; storage stability |
| 12/30/2004 | US20040265242 Administering drug to the respiratory tract of patient in a lower dosage than orally; treating Parkinson's or Alzheimer's disease; sleep, attention deficit hyperactivity, bipolar, and psychological disorders; headaches, antiepileptic agents; rescue therapy for a panic attack |
| 12/30/2004 | DE10326303A1 Reagenzien zur Modifikation von Biopharmazeutika, deren Herstellung und Anwendung Reagents for the modification of biopharmaceuticals, their preparation and application |
| 12/30/2004 | DE10325752A1 Lektin-Konjugate Lectin conjugates |
| 12/29/2004 | WO2004113383A2 Pegylated soluble gp130-dimers useful as a medicament |
| 12/29/2004 | WO2004112891A1 Implantable stimulation electrode with a coating for increasing tissue compatibility |
| 12/29/2004 | WO2004112837A1 PREPARATION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND INTERLEUKIN-1α PRODUCTION INHIBITOR |
| 12/29/2004 | WO2004112836A2 Ophthalmic compositions containing a synergistic combination of two polymers |
| 12/29/2004 | WO2004112828A1 Liquid composition of factor vii polypeptides |
| 12/29/2004 | WO2004112827A1 Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 12/29/2004 | WO2004112826A1 Freeze-dried fsh / lh formulations |
| 12/29/2004 | WO2004112814A1 Nail restructuring compositions for topical application |
| 12/29/2004 | WO2004112799A1 Methods and apparatus for producing nanoscale particles |
| 12/29/2004 | WO2004112789A1 Ophthalmic composition |
| 12/29/2004 | WO2004112778A1 Cisplatin preparation and process for producing the same |
| 12/29/2004 | WO2004112770A1 Adhesive patch containing tulobuterol |
| 12/29/2004 | WO2004112758A1 Hyaluronic acid nanoparticles |
| 12/29/2004 | WO2004112757A1 Pharmaceutical compositions comprising ph-sensitive block copolymers and a hydrophobic drug |
| 12/29/2004 | WO2004112752A1 Method of preparing mixed formulation of sustained release microspheres by continuous one-step process |
| 12/29/2004 | WO2004112751A1 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 12/29/2004 | WO2004112747A2 Specific delivery of drugs to the brain |
| 12/29/2004 | WO2004112717A2 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof |
| 12/29/2004 | WO2004112713A2 Drug polymer complexes |
| 12/29/2004 | WO2004112630A2 A formulation and a process for reducing the deterioration of blood with particular reference to decrease in the level of 2,3 diphosphoglycerate during storage |
| 12/29/2004 | WO2004112590A2 Methods of enhancing radiation effects with metal nanoparticles |
| 12/29/2004 | WO2004112566A2 Diagnosis and treatment of nephropathy |
| 12/29/2004 | WO2004112482A2 Biological active coating components, coatings, and coated surfaces |